Qualitative Study on Osteoporosis Representation and Management in the General Population and in General Practitioners.
NCT ID: NCT02861989
Last Updated: 2016-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
114 participants
OBSERVATIONAL
2014-02-28
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators implemented a qualitative study to explore the knowledge and representations regarding osteoporosis in the general and at-risk population and in doctors in Rhône-Alpes Region, France, using focus groups with women and men and semi-structured face-to-face interviews with general practitioners. Understanding barriers to osteoporosis care in patients and general practitioners will help to set up effective strategies to improve prevention and treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an Osteoporosis Prevention Strategy in Women With Osteoporotic Fracture of the Upper Limb
NCT01780012
Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients
NCT04029870
Primary Care Management of Osteoporosis in Older Women
NCT06431867
Qualitative Study Exploring the Determinants Involved in the Management of Osteoporosis in Frail Elderly People
NCT07303166
Strategies to Treat Osteoporosis Following a Fragility Fracture
NCT00512499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Osteoporotic women
women over 50 years with a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment
qualitative study
At risk women
women over 50 years without a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment
qualitative study
Osteoporotic men
Men over 60 years with a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment
qualitative study
At-risk men
Men over 60 years without a diagnosis of osteoporosis or history of fragility fracture /osteoporosis treatment
qualitative study
General practitioners
General practitioners from the Rhône area, France
qualitative study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
qualitative study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* group 2: women aged 50 to 85 years without a history of fragility fracture or an osteoporosis diagnostic
* group 3: men aged 60 to 85 years with a history of fragility fracture or an osteoporosis diagnostic
* group 4: men aged 60 to 85 years without a history of fragility fracture or an osteoporosis diagnostic
* group 5: general practitioners in Region Rhône-Alpes, France
* who signed the consent form
Exclusion Criteria
* legal disability
* difficulty in understanding French
* psychiatric disorder
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne-Marie Schott, Pr
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pôle IMER, Hospices Civils de Lyon
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL16_0499
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.